Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by whippeton Aug 31, 2017 9:29am
126 Views
Post# 26641249

RE:Estimated 2018 year end revenue

RE:Estimated 2018 year end revenue
Hi Seg, 

i like your estimates, but as far as revenues   i would use the number that management as for F2018 target which is 6.6M
Also, they implimented a program where expenses should be a little lower. the additionnal expenses would come from new contracts. (which would mean also more revenues.)  Also most of the equipement expenses for Mexico were already made in last year. So we dont need to buy more equipement for the new contract. :)
with what we know, i would use more profits of 1.5M  or close to C.01 plus the potential and growth in the next years.

In other word, we are trading very cheap.
Just my opinion.
whip.
Bullboard Posts